Q2 Results for Fy27: Dabur India and Exide Industries Report Strong Profit Growth; Apollo Hospitals in Focus
The September quarter earnings season has brought important updates for investors as several major Indian companies have announced their Q2 FY27 financial results. Among the companies in focus are Apollo Hospitals Enterprise, Dabur India and Exide Industries.
These companies operate in different sectors, including healthcare, FMCG and automobile batteries. Their latest quarterly performance offers investors an opportunity to understand how businesses are performing amid changing market conditions.
While Dabur India and Exide Industries have reported their Q2 results, Apollo Hospitals is also in focus as investors await its latest financial performance.
Read Also – https://fingossip.com/melstar-stock-return-3365-percent-relisting/
Dabur India Q2 Results: Revenue and Profit Show Healthy Growth
Dabur India reported a positive performance in the second quarter of FY27. The FMCG company recorded consolidated revenue from operations of approximately ₹3,563 crore, showing an increase of 11.7% compared with the same quarter last year.
The company’s consolidated net profit increased by around 12.1% year-on-year to ₹498.6 crore. This growth indicates that Dabur maintained a positive financial performance during the September quarter.
Dabur is known for its products across healthcare, personal care, home care and food categories. Its popular brands include Dabur Chyawanprash, Real, Vatika and Dabur Honey.
The company’s performance is important because consumer demand and household spending play a major role in the FMCG sector. Revenue growth and higher profitability can support business expansion and strengthen investor confidence.
Dabur also announced an interim dividend-related update for FY27. Investors will be watching the company’s future demand trends, product sales and profit margins in the coming quarters.
Exide Industries Q2 Results: Net Profit Jumps 65%
Exide Industries delivered strong year-on-year profit growth in Q2 FY27. The battery manufacturer reported consolidated revenue from operations of ₹5,291.9 crore for the September quarter, representing an increase of approximately 21.2% compared with ₹4,364.5 crore in the corresponding quarter last year.
The company’s consolidated net profit stood at ₹287.1 crore, rising 65.4% from ₹173.6 crore in Q2 FY26.
Operating performance also improved significantly. Operating profit increased by around 91.2% year-on-year, while the operating margin improved to 7.9% compared with 5.7% in the year-ago quarter.
However, the company reported a sequential decline in its financial performance. Revenue decreased from ₹5,528.4 crore in Q1 FY27 to ₹5,291.9 crore in Q2 FY27. Net profit also declined from ₹351.3 crore to ₹287.1 crore.
Exide Industries is one of India’s leading battery manufacturers, serving automotive, industrial and other battery markets. The company is also investing in battery technology and lithium-ion battery manufacturing through its subsidiary, Exide Energy Solutions.
Investors will closely monitor the company’s operating margins, demand from automobile manufacturers and progress in its new energy business.
Read Also – https://fingossip.com/festive-shopping-rising-interest-rates-india/
Apollo Hospitals Enterprise is another important company attracting investor attention during the Q2 FY27 earnings season.
The company operates a large healthcare network that includes hospitals, pharmacies, diagnostics and digital healthcare services. Its quarterly performance is closely watched because demand for healthcare services and hospital occupancy can influence its financial growth.
In Q1 FY27, Apollo Hospitals reported consolidated revenue of ₹7,043.5 crore, representing year-on-year growth of approximately 20.6%. Its net profit increased to ₹610.4 crore, compared with ₹441 crore in Q1 FY26.
These numbers provided a strong starting point for the financial year.
For Q2 FY27, investors will be looking at revenue growth, hospital business performance, operating margins and profitability. The company’s expansion plans and healthcare service demand will also remain important factors.
However, its final Q2 FY27 financial figures could not be independently verified at the time of writing. Therefore, investors should refer to the company’s official exchange filing for the confirmed results.
Overall, the Q2 FY27 results of Dabur India and Exide Industries show healthy year-on-year profit growth, while Apollo Hospitals remains an important company to watch in the healthcare sector.
For investors, the key takeaway is that revenue growth, profit margins and future business outlook are equally important when evaluating quarterly results. A strong quarterly profit does not automatically mean that a stock is a good investment. Investors should also consider company valuations, future growth opportunities and market conditions before making any investment decision.
Disclaimer: This article is for informational and educational purposes only. It is not investment advice. Investors should conduct their own research before buying or selling any stock.